Centrum 7/6  banner

NACDS

Dr. Lauren Lyles-Stolz joins NACDS as senior director of Reimbursement, Innovation and Advocacy

Dr. Lauren Lyles-Stolz joins NACDS as senior director of Reimbursement, Innovation and Advocacy

ARLINGTON, Va. – Dr. Lauren Lyles-Stolz, PharmD, has joined the staff team of the National Association of Chain Drug Stores (NACDS). She fills the new role of senior director of reimbursement, innovation and advocacy. Most recently, she served as health legislative assistant for U.S. Rep. Bradley S. Schneider (D-Ill.). At NACDS, she will serve as

NACDS-backed federal action expanding patient access to O-T-C hearing aids now in effect

NACDS-backed federal action expanding patient access to O-T-C hearing aids now in effect

ARLINGTON, Va. – As of October 17, for the first time, American adults with mild-to-moderate hearing loss have the ability to buy hearing aids on an over-the-counter (OTC) basis at retailers across the country.    The National Association of Chain Drug Stores (NACDS)-backed move — which will greatly enhance patients’ access to hearing aids — comes out

NACDS brings “face of neighborhood health care” to White House Conference

NACDS brings “face of neighborhood health care” to White House Conference

WASHINGTON – NACDS members have served with “lights on, doors open” in the nation’s COVID-19 response. At today’s White House Conference on Hunger, Nutrition and Health, the Association is reminding policymakers and collaborators that broader health and wellness solutions also can be found as close as the nearest pharmacy. NACDS president & CEO Steven C.

NACDS’ open letter to President urges action on recommendations vital for public health

NACDS’ open letter to President urges action on recommendations vital for public health

ARLINGTON, Va. – On September 22, 2022, NACDS issued the following open letter: Dear President Biden and the White House COVID-19 Task Force: Thank you for your engagement and leadership throughout the COVID-19 pandemic. The National Association of Chain Drug Stores (NACDS) represents regional and national drug stores, supermarkets, and mass merchants with pharmacies. The

Boston Business Journal welcomes NACDS Total Store Expo

Boston Business Journal welcomes NACDS Total Store Expo

ARLINGTON, Va. — With the 2022 NACDS Total Store Expo set to launch, the Boston Business Journal this morning published an op-ed authored by NACDS President & CEO Steven Anderson.  The opinion piece centers on the pharmacy industry’s mighty and ongoing role in the COVID-19 response; legislative action that must be taken to help sustain Americans’ access

NACDS Total Store Expo: What to know before you go

NACDS Total Store Expo: What to know before you go

BOSTON — The 2022 National Association of Chain Drug Stores (NACDS) Total Store Expo kicks off August 27-29. The highly anticipated event — returning in-person for the first time since 2019 — will bring together NACDS-member retailers and suppliers nationwide to Boston, Mass., for vibrant discussion and collaboration.   Check out the NACDS Total Store Expo “Know

NACDS adds two professionals to Congressional relations function

NACDS adds two professionals to Congressional relations function

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) announced on Monday the appointment of and Whitney Jones, each in the role of director of Congressional relations. Ilahi has served as director of government relations for 340B Health since January 2020. Jones has served as health policy analyst for the U.S. Senate Republican

NACDS advises White House Conference on Hunger, Nutrition and Health

NACDS advises White House Conference on Hunger, Nutrition and Health

WASHINGTON — As part of the bold “NACDS 2023” initiative, NACDS has issued recommendations for the upcoming White House Conference on Hunger, Nutrition, and Health and for the Biden Administration’s policy agenda on these issues. Described by the NACDS leadership during the 2022 NACDS Annual Meeting, “NACDS 2023” is a strategic approach that reflects NACDS chain and

NACDS offers recommendations to Biden Administration to help operationalize pharmacist prescribing of COVID antivirals

NACDS offers recommendations to Biden Administration to help operationalize pharmacist prescribing of COVID antivirals

ARLINGTON, Va. — NACDS submitted on Tuesday recommendations to the Biden Administration that would help operationalize improved access to Paxlovid (nirmatrelvir and ritonavir) and maximize public benefit of this treatment, particularly among individuals at high-risk of progression to severe COVID-19. READ LETTER NACDS’ recommendations follow the July 6 announcement by the U.S. Food and Drug

Pharmacy groups applaud FDA’s action on pharmacist-prescribed COVID-19 antivirals

Pharmacy groups applaud FDA’s action on pharmacist-prescribed COVID-19 antivirals

WASHINGTON – Pharmacy groups praised the U.S. Food and Drug Administration on the revised Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. “The FDA’s action is an extremely important revision for patient access

PP_1170x120_10-25-21